Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum COSCIENS Biopharma Inc T.AEZS

COSCIENS Biopharma Inc., formerly Aeterna Zentaris Inc., is a specialty biopharmaceutical company engaged in the development and commercialization of a diverse portfolio of pharmaceutical and diagnostic products, including those focused on areas of unmet medical need. Its lead product, macimorelin (Macrilen; Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone... see more

TSX:AEZS - Post Discussion

COSCIENS Biopharma Inc > For CZO shareholders
View:
Post by prophetoffactz on Jun 07, 2024 8:58am

For CZO shareholders

Schellaj wrote:My shares though BMO Investorline have yet to be switched over as well. No response from Ceapro either.  Not a very comfortable situation right now. 
Some CZO shareholders hadn't received their shares yet...


CZO's Feb.15, 2024 SEDAR filing said:

Non-Registered Shareholders The exchange of Shares for the Consideration Shares in respect of Non-Registered Shareholders is expected to be made with such Shareholders’ Intermediary. Non-Registered Shareholders should contact their Intermediary if they have any questions regarding this process and carefully follow the instructions from the Intermediary that holds their Shares and arrange for their Intermediary to complete the necessary steps to ensure that they receive the Consideration for their Shares as soon as possible following completion of the Arrangement
Comment by Schellaj on Jun 07, 2024 9:49am
I'm in contact with BMO Investorline and they are currently looking into it.  I will update when I have more info. 
Comment by Schellaj on Jun 07, 2024 3:50pm
BMO got back to me and said that the shares are set to switch over to AEZS for the 11th.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities